Sulforaphane inhibits the activation of hepatic stellate cell by miRNA-423-5p targeting suppressor of fused
Authors:
- 5 July 2019
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 32 (4) , 403-410
Abstract
Liver fibrosis, a common pathological process in chronic liver diseases, is characterized by excessive accumulation of extracellular matrix proteins and considered as a wound healing response to chronic liver injury. Hepatic stellate cell (HSC) activation plays a key role in liver fibrosis development. Previous studies showed that sulforaphane (SFN) has wide protective effects against tissue injury and inflammation. Accumulating evidence has shown that microRNAs play important roles in the development of hepatic fibrosis, some of which have been identified as potential therapeutic targets. This study was conducted to explore the role of SFN in the suppression of HSC activation. Quantitative real-time PCR showed that HSC miR-423-5p levels were up-regulated during HSC activation and down-regulated after SFN administration. Further, transfection of a miR-423-5p mimic demonstrated that inhibition of HSC activation by SFN required down-regulation of miR-423-5p. We showed that suppressor of fused is the direct target of miR-423-5p. SFN may play a role in inhibiting hepatic fibrosis by downregulating miRNA-423-5p. MiRNA-423-5p may be useful as a therapeutic target for treating hepatic fibrosis.Keywords
Funding Information
- National Natural Science Foundation of China (81704016)
- Natural Science Foundation of Guangdong Province (2017A030313687)
This publication has 37 references indexed in Scilit:
- Overlapping activities of TGF-β and Hedgehog signaling in cancer: Therapeutic targets for cancer treatmentPharmacology & Therapeutics, 2013
- Hepatic fibrosisCurrent Opinion in Gastroenterology, 2009
- Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategiesJournal of Gastroenterology, 2008
- MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed PairingMolecular Cell, 2007
- Role for Hedgehog signaling in hepatic stellate cell activation and viabilityLaboratory Investigation, 2005
- Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantationDigestive and Liver Disease, 2005
- Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosisGut, 2004
- Specificity of microRNA target selection in translational repressionGenes & Development, 2004
- The Role of Smad3 in Mediating Mouse Hepatic Stellate Cell ActivationHepatology, 2001
- Cytokine Regulation of Hepatic Stellate Cells in Liver FibrosisAlcohol, Clinical and Experimental Research, 1999